The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited
Open accessAbstract
Hyperinsulinemia and insulin resistance were proposed more than 30 years ago to be important contributors to elevated blood pressure (BP) associated with obesity and the metabolic syndrome, also called syndrome X. Support for this concept initially came from clinical and population studies showing correlations among hyperinsulinemia, insulin resistance and elevated BP in individuals with metabolic syndrome. Short-term studies in experimental animals and in humans provided additional evidence that hyperinsulinemia may evoke increases in sympathetic nervous system (SNS) activity and renal sodium retention that, if sustained, could increase BP. Although insulin infusions may increase SNS activity and modestly raise BP in rodents, chronic insulin administration does not significantly increase BP in lean or obese insulin resistant rabbits, dogs, horses, or humans. Multiple studies in humans and experimental animals have also shown that severe insulin resistance and hyperinsulinemia may occur in the absence of elevated BP. These observations question whether insulin resistance and hyperinsulinemia are major factors linking obesity/metabolic syndrome with hypertension. Other mechanisms, such as physical compression of the kidneys, activation of the renin-angiotensin-aldosterone system, hyperleptinemia, stimulation of the brain melanocortin system, and SNS activation appear to play a more critical role in initiating hypertension in obese subjects with metabolic syndrome. However, the metabolic effects of insulin resistance, including hyperglycemia and dyslipidemia, appear to interact synergistically with increased BP to cause vascular and kidney injury which can exacerbate the hypertension and associated injury to the kidneys and cardiovascular system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,594
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
A comprehensive definition for metabolic syndrome
Huang, P. L. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001180 · Cited by 2,214
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687
The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.7.1514 · Cited by 1,516
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360
Self-citationWilliams, B., MacDonald, T. M., Morant, S., Webb, D. J., Sever, P., McInnes, G., Ford, I., Cruickshank, J. K., Caulfield, M. J., Salsbury, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00257-3 · Cited by 1,308
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.
DeFronzo, R. A., Cooke, C. R., Andres, R., Faloona, G. R., & Davis, P. J. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107996 · Cited by 1,115
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Receptor-mediated regional sympathetic nerve activation by leptin.
Haynes, W. G., Morgan, D. A., Walsh, S. A., Mark, A. L., & Sivitz, W. I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119532 · Cited by 979
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Neeland, I. J., Poirier, P., & Després, J.-P. (2018) · Circulation · doi:10.1161/circulationaha.117.029617 · Cited by 881
The Kidney, Hypertension, and Obesity
Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000052314.95497.78 · Cited by 868
Self-citationIncidence and precursors of hypertension in young adults: The Framingham offspring study
Garrison, R. J., Kannel, W. B., Stokes, J., & Castelli, W. P. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90087-9 · Cited by 789
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753
Ozata, M., Ozdemir, I. C., & Licinio, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.5999 · Cited by 739
Chronic Leptin Infusion Increases Arterial Pressure
Shek, E. W., Brands, M. W., & Hall, J. E. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.409 · Cited by 686
Self-citationObesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654
Self-citationThe Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
The pathophysiology of hypertension in patients with obesity
DeMarco, V. G., Aroor, A. R., & Sowers, J. R. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.44 · Cited by 545
The Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
Tao, Y.-X. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0037 · Cited by 531
Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins
Hall, J. E., da Silva, A. A., do Carmo, J. M., Dubinion, J., Hamza, S., Munusamy, S., Smith, G., & Stec, D. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.113175 · Cited by 528
Self-citationObesity, hypertension, and chronic kidney disease
Hall, J., Juncos, L., Wang, Z., Hall, M., do Carmo, J., & da Silva, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s39739 · Cited by 520
Self-citationIntra‐abdominal pressure, sagittal abdominal diameter and obesity comorbidity
SUGERMAN, H., WINDSOR, A., BESSOS, M., & WOLFE, L. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.89104000.x · Cited by 486
Modulation of Blood Pressure by Central Melanocortinergic Pathways
Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., Cameron, G. S., Astruc, B., Mayer, J. P., Brage, S., See, T. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803085 · Cited by 477
Pathophysiological role of leptin in obesity-related hypertension
Aizawa-Abe, M., Ogawa, Y., Masuzaki, H., Ebihara, K., Satoh, N., Iwai, H., Matsuoka, N., Hayashi, T., Hosoda, K., Inoue, G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8341 · Cited by 477
Atchley, D. W., Loeb, R. F., Richards, D. W., Benedict, E. M., & Driscoll, M. E. (1933) · Journal of Clinical Investigation · doi:10.1172/jci100504 · Cited by 396
Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic
Haynes, W. G., Morgan, D. A., Djalali, A., Sivitz, W. I., & Mark, A. L. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.542 · Cited by 358
Fatty Kidney, Hypertension, and Chronic Kidney Disease: The Framingham Heart Study
Foster, M. C., Hwang, S.-J., Porter, S. A., Massaro, J. M., Hoffmann, U., & Fox, C. S. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.175315 · Cited by 356
Sympathetic and Cardiorenal Actions of Leptin
Haynes, W. G., Sivitz, W. I., Morgan, D. A., Walsh, S. A., & Mark, A. L. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.619 · Cited by 349
Williams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., Ford, I., Cruickshank, J. K., Caulfield, M. J., Padmanabhan, S., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30071-8 · Cited by 347
Berne, C., Fagius, J., Pollare, T., & Hjemdahl, P. (1992) · Diabetologia · doi:10.1007/bf00399935 · Cited by 293
Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity
Carlyle, M., Jones, O. B., Kuo, J. J., & Hall, J. E. (2002) · Hypertension · doi:10.1161/hy0202.104398 · Cited by 292
Self-citationVollenweider, P., Randin, D., Tappy, L., Jéquier, E., Nicod, P., & Scherrer, U. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117242 · Cited by 285
Obesity and hypertension: two epidemics or one?
Davy, K. P., & Hall, J. E. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00707.2003 · Cited by 280
Self-citationThe melanocortin pathway and control of appetite-progress and therapeutic implications
Baldini, G., & Phelan, K. D. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0596 · Cited by 272
Friedman, J. (2016) · Journal of Clinical Investigation · doi:10.1172/jci91578 · Cited by 270
Is obesity a major cause of chronic kidney disease?
Hall, J. E., Henegar, J. R., Dwyer, T. M., Liu, J., da Silva, A. A., Kuo, J. J., & Tallam, L. (2004) · Advances in Renal Replacement Therapy · doi:10.1053/j.arrt.2003.10.007 · Cited by 264
Self-citationThe Relationship of Body Mass and Fat Distribution With Incident Hypertension
Chandra, A., Neeland, I. J., Berry, J. D., Ayers, C. R., Rohatgi, A., Das, S. R., Khera, A., McGuire, D. K., de Lemos, J. A., & Turer, A. T. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.057 · Cited by 264
Mark, A. L., Shaffer, R. A., Correia, M. L. G., Morgan, D. A., Sigmund, C. D., & Haynes, W. G. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917121-00026 · Cited by 254
Reaven, G. M. (1994) · PubMed · Cited by 241
The hemodynamic link between insulin resistance and hypertension
Julius, S., Gudbrandsson, T., Jamerson, K., Shahab, S. T., & Andersson, O. (1991) · Journal of Hypertension · doi:10.1097/00004872-199111000-00001 · Cited by 240
Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension
de Souza, F., Muxfeldt, E., Fiszman, R., & Salles, G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.140988 · Cited by 234
Hypertension: Physiology and Pathophysiology
Hall, J. E., Granger, J. P., do Carmo, J. M., da Silva, A. A., Dubinion, J., George, E., Hamza, S., Speed, J., & Hall, M. E. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110058 · Cited by 232
Self-citationThe renin-angiotensin system and natriuretic peptides in obesity-associated hypertension
Engeli, S., & Sharma, A. M. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090000144 · Cited by 225
Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans.
Anderson, E. A., Balon, T. W., Hoffman, R. P., Sinkey, C. A., & Mark, A. L. (1992) · Hypertension · doi:10.1161/01.hyp.19.6.621 · Cited by 221
Sleep Apnea and Cardiovascular Disease: An Enigmatic Risk Factor
Floras, J. S. (2018) · Circulation Research · doi:10.1161/circresaha.118.310783 · Cited by 209
Obesity, Metabolism, and the Sympathetic Nervous System
Landsberg, L., & Krieger, D. R. (1989) · American Journal of Hypertension · doi:10.1093/ajh/2.3.125s · Cited by 208
Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration
de Paula, R. B., da Silva, A. A., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000105624.68174.00 · Cited by 207
Self-citationHypertension in Obese Zucker Rats: Role of Angiotensin II and Adrenergic Activity
Alonso-Galicia, M., Brands, M. W., Zappe, D. H., & Hall, J. E. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.1047 · Cited by 200
Self-citationMelanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment
Kühnen, P., Krude, H., & Biebermann, H. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.12.002 · Cited by 190
Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin
Rahmouni, K., Haynes, W. G., Morgan, D. A., & Mark, A. L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-14-05998.2003 · Cited by 185
Chughtai, H. L., Morgan, T. M., Rocco, M., Stacey, B., Brinkley, T. E., Ding, J., Nicklas, B., Hamilton, C., & Hundley, W. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157370 · Cited by 172
Obesity, the sympathetic nervous system, and essential hypertension.
Tuck, M. L. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i67 · Cited by 171
Tallam, L. S., Stec, D. E., Willis, M. A., da Silva, A. A., & Hall, J. E. (2005) · Hypertension · doi:10.1161/01.hyp.0000175474.99326.bf · Cited by 151
Self-citationEssential Hypertension: An Insulin-Resistant State
Ferrannini, E., Haffner, S. M., & Stern, M. P. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000005-00004 · Cited by 149
Sex Differences in Mechanisms of Hypertension Associated With Obesity
Faulkner, J., & de Chantemèle, E. J. B. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09980 · Cited by 139
Control by insulin of sodium potassium and water excretion by the isolated dog kidney
Nizet, A., Lefèbvre, P., & Crabb�, J. (1971) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00586561 · Cited by 138
Mechanisms of Insulin Action on Sympathetic Nerve Activity
Muntzel, M. S., Anderson, E. A., Johnson, A. K., & Mark, A. L. (1995) · Clinical and Experimental Hypertension · doi:10.3109/10641969509087053 · Cited by 137
Sustained hyperinsulinemia increases arterial pressure in conscious rats
Brands, M. W., Hildebrandt, D. A., Mizelle, H. L., & Hall, J. E. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.260.4.r764 · Cited by 136
Self-citationIntracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity
Muntzel, M. S., Morgan, D. A., Mark, A. L., & Johnson, A. K. (1994) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1994.267.5.r1350 · Cited by 134
Is insulin the link between hypertension and obesity?
Christlieb, A. R., Krolewski, A. S., Warram, J. H., & Soeldner, J. S. (1985) · Hypertension · doi:10.1161/01.hyp.7.6_pt_2.ii54 · Cited by 128
do Carmo, J. M., da Silva, A. A., Cai, Z., Lin, S., Dubinion, J. H., & Hall, J. E. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.161349 · Cited by 127
Self-citationMechanism of Salt-Sensitive Hypertension: Focus on Adrenal and Sympathetic Nervous Systems
Fujita, T. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121258 · Cited by 124
Cassaglia, P. A., Hermes, S. M., Aicher, S. A., & Brooks, V. L. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.205575 · Cited by 119
Ward, K. R., Bardgett, J. F., Wolfgang, L., & Stocker, S. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.160671 · Cited by 118
Chronic hyperinsulinemia and blood pressure regulation
Hall, J. E., Coleman, T. G., Mizelle, H. L., & Smith, M. J. (1990) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1990.258.3.f722 · Cited by 118
Self-citationda Silva, A. A., Kuo, J. J., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000128421.23499.b9 · Cited by 117
Chronic hyperinsulinemia and blood pressure. Interaction with catecholamines?
Hall, J. E., Brands, M. W., Kivlighn, S. D., Mizelle, H. L., Hildebrandt, D. A., & Gaillard, C. A. (1990) · Hypertension · doi:10.1161/01.hyp.15.5.519 · Cited by 116
Self-citationHYPERTENSION AND HYPERINSULINAEMIA: A RELATION IN DIABETES BUT NOT ESSENTIAL HYPERTENSION
Mbanya, J. C., Wilkinson, R., Thomas, T. H., George, K., Alberti, M. M., & Taylor, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91538-3 · Cited by 116
Inhibition of NO Synthesis Enhances Chronic Cardiovascular and Renal Actions of Leptin
Kuo, J. J., Jones, O. B., & Hall, J. E. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.670 · Cited by 114
Self-citationHypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function
Kuo, J. J., Silva, A. A., & Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000048194.97428.1a · Cited by 113
Self-citationRelationship Between Muscle Sympathetic Nerve Activity and Plasma Leptin Concentration
Snitker, S., Pratley, R. E., Nicolson, M., Tataranni, P. A., & Ravussin, E. (1997) · Obesity Research · doi:10.1002/j.1550-8528.1997.tb00561.x · Cited by 110
Dunbar, J. C., & Lu, H. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00197-5 · Cited by 100
The Hemodynamic Response to Chronic Hyperinsulinemia in Conscious Dogs
Brands, M. W., Mizelle, H. L., Gaillard, S., Hildebrandt, D. A., & Hall, J. E. (1991) · American Journal of Hypertension · doi:10.1093/ajh/4.2.164 · Cited by 96
Self-citationObesity-Related Hypertension and the Role of Insulin and Leptin in High-Fat–Fed Rabbits
Lim, K., Burke, S. L., & Head, G. A. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00705 · Cited by 95
Catheter-Based Radiorefrequency Renal Denervation Lowers Blood Pressure in Obese Hypertensive Dogs
Henegar, J. R., Zhang, Y., Rama, R. D., Hata, C., Hall, M. E., & Hall, J. E. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu048 · Cited by 89
Self-citationSympathetic Function in Human Carriers of Melanocortin-4 Receptor Gene Mutations
Sayk, F., Heutling, D., Dodt, C., Iwen, K. A., Wellhoner, J. P., Scherag, S., Hinney, A., Hebebrand, J., & Lehnert, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2297 · Cited by 86
Hypotensive and sedative effects of insulin in autonomic failure.
Mathias, C. J., da Costa, D. F., Fosbraey, P., Christensen, N. J., & Bannister, R. (1987) · BMJ · doi:10.1136/bmj.295.6591.161 · Cited by 84
Resistance to Metabolic Actions of Insulin and Its Role in Hypertension
Hall, J. E., Summers, R. L., Brands, M. W., Keen, H. L., & Alonso‐Galicia, M. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.8.772 · Cited by 84
Self-citationApparent mineralocorticoid excess
Funder, J. W. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.010 · Cited by 83
Hemodynamic and Renal Responses to Chronic Hyperinsulinemia in Obese, Insulin-Resistant Dogs
Hall, J. E., Brands, M. W., Zappe, D., Dixon, W. N., Mizelle, H. L., Reinhart, G. A., & Hildebrandt, D. A. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.994 · Cited by 83
Self-citationHall, J. E., Brands, M. W., Zappe, D. H., & Galicia, M. A. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-208-43862b · Cited by 82
Self-citation[Epidermiology and associated risk factors of hyperlipoproteinemia].
Haller, H. (1977) · PubMed · Cited by 80
Insulin and renal sodium handling: clinical implications.
DeFronzo, R. A. (1981) · PubMed · Cited by 80
Lack of association between blood pressure and insulin in patients with insulinoma
Tsutsu, N., Nunoi, K., Kodama, T., Nomiyama, R., Iwase, M., & FUJISHIMA, M. (1990) · Journal of Hypertension · doi:10.1097/00004872-199005000-00014 · Cited by 78
Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma
Sawicki, P. T., Heinemann, L., Starke, A., & Berger, M. (1992) · Diabetologia · doi:10.1007/bf00400257 · Cited by 75
Antidiuresis Associated With Administration of Insulin
Miller, J. H., & Bogdonoff, M. D. (1954) · Journal of Applied Physiology · doi:10.1152/jappl.1954.6.8.509 · Cited by 74
Device-Based Neuromodulation for Resistant Hypertension Therapy: Too Early for Prime Time?
Lohmeier, T. E., & Hall, J. E. (2019) · Circulation Research · doi:10.1161/circresaha.118.313221 · Cited by 74
Self-citationHyperinsulinemia: A link between obesity and hypertension?
Hall, J. E. (1993) · Kidney International · doi:10.1038/ki.1993.197 · Cited by 73
Self-citationPhenotypic Characterization of Insulin-Resistant and Insulin-Sensitive Obesity
Chen, D., Liess, C., Poljak, A., Xu, A., Zhang, J.-L., Thoma, C., Trenell, M. I., Milner, B., Jenkins, A. B., Chisholm, D. J., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2712 · Cited by 73
Greenfield, J. R. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02088.x · Cited by 72
Bardgett, M. E., McCarthy, J. J., & Stocker, S. D. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.146605 · Cited by 71
Jordan, J., Birkenfeld, A. L., Melander, O., & Moro, C. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11081 · Cited by 68
Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation
Kuo, J. J., da Silva, A. A., Tallam, L. S., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000111836.54204.93 · Cited by 68
Self-citationContrasting Autonomic and Hemodynamic Effects of Insulin in Healthy Elderly Versus Young Subjects
Hausberg, M., Hoffman, R. P., Somers, V. K., Sinkey, C. A., Mark, A. L., & Anderson, E. A. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.700 · Cited by 68
Chronic intrarenal hyperinsulinemia does not cause hypertension
Hall, J. E., Brands, M. W., Mizelle, H. L., Gaillard, S., & Hildebrandt, D. A. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.260.5.f663 · Cited by 67
Self-citationInsulin-Induced Hypertension in Rats Depends on an Intact Renin-Angiotensin System
Brands, M. W., Harrison, D. L., Keen, H. L., et al. (1997) · Hypertension · doi:10.1161/01.hyp.29.4.1014 · Cited by 66
Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive.
Brands, M. W., Hildebrandt, D. A., Mizelle, H. L., & Hall, J. E. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i83 · Cited by 62
Self-citationMachleidt, F., Simon, P., Krapalis, A. F., Hallschmid, M., Lehnert, H., & Sayk, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3009 · Cited by 61
Esler, M., Lambert, G., Schlaich, M., Dixon, J., Sari, C. I., & Lambert, E. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.09790 · Cited by 60
Does Chronic Hyperinsulinemia Cause Hypertension?
Hall, J. E., Coleman, T. G., & Mizelle, H. L. (1989) · American Journal of Hypertension · doi:10.1093/ajh/2.3.171 · Cited by 57
Self-citationUse of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension
Dudenbostel, T., & Calhoun, D. A. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpw105 · Cited by 51
Patients with insulinoma show insulin resistance in the absence of arterial hypertension
Pontiroli, A. E., Alberetto, M., & Pozza, G. (1992) · Diabetologia · doi:10.1007/bf00400934 · Cited by 48
The Brain Melanocortin System, Sympathetic Control, and Obesity Hypertension
da Silva, A. A., do Carmo, J. M., Wang, Z., & Hall, J. E. (2014) · Physiology · doi:10.1152/physiol.00061.2013 · Cited by 47
Self-citationInhibition of Thromboxane Synthesis Attenuates Insulin Hypertension in Rats
Keen, H. L. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00217-3 · Cited by 47
Arshi, B., Tohidi, M., Derakhshan, A., Asgari, S., Azizi, F., & Hadaegh, F. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2014.70 · Cited by 44
Arcuate nucleus injection of an anti-insulin affibody prevents the sympathetic response to insulin
Luckett, B. S., Frielle, J., Wolfgang, L., & Stocker, S. D. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00081.2013 · Cited by 43
Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension
da Silva, A. A., do Carmo, J. M., Wang, Z., & Hall, J. E. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0951-x · Cited by 41
Self-citationCARDIOVASCULAR ACTIONS OF INSULIN: ARE THEY IMPORTANT IN LONG‐TERM BLOOD PRESSURE REGULATION?
Hall, J. E., Brands, M. W., Zappe, D., & Alonso‐Galicia, M. (1995) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1995.tb01922.x · Cited by 38
Self-citationTsioufis, C. P., Ziakas, A., Dimitriadis, K. S., Davlouros, P. A., Marketou, M. E., Kasiakogias, A., Thomopoulos, C., Petroglou, D., Tsiachris, D., Doumas, M. N., et al. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1056-z · Cited by 36
Bomback, A. S., Muskala, P., Bald, E., Chwatko, G., & Nowicki, M. (2009) · Clinical Nephrology · doi:10.5414/cnp72449 · Cited by 34
Insulin resistance, hyperinsulinemia, and obesity-associated hypertension.
Brands, M. W., & Hall, J. E. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v351064 · Cited by 34
Self-citationChronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats
KEEN, H., BRANDS, M., Alonso‐Galicia, M., & Hall, J. E. (1996) · American Journal of Hypertension · doi:10.1016/s0895-7061(96)00254-3 · Cited by 31
Self-citationFaulkner, J., & de Chantemèle, E. J. B. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.09.003 · Cited by 30
Normal blood pressure in patients with insulinoma despite hyperinsulinemia and insulin resistance.
Sawicki, P., Baba, T., Berger, M., & Starke, A. C. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v34s64 · Cited by 28
Stocker, S. D., & Gordon, K. W. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00764.2014 · Cited by 27
Dai, S., Huang, B., Zou, Y., & Liu, Y. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.72609 · Cited by 26
Sex differences in the sympathoexcitatory response to insulin in obese rats: role of neuropeptide Y
Shi, Z., Cassaglia, P. A., Pelletier, N. E., & Brooks, V. L. (2019) · The Journal of Physiology · doi:10.1113/jp277517 · Cited by 25
do Carmo, J. M., da Silva, A. A., Gava, F. N., Moak, S. P., Dai, X., & Hall, J. E. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00077.2019 · Cited by 19
Self-citationChronic central nervous system hyperinsulinemia and regulation of arterial pressure and food intake
Liu, J., da Silva, A. A., Tallam, L. S., & Hall, J. E. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000234120.71142.6c · Cited by 16
Self-citationAcute effects of insulin on circulating natriuretic peptide levels in humans
Bachmann, K. N., Değer, S. M., Alsouqi, A., Huang, S., Xu, M. J., Ferguson, J. F., Su, Y. R., Niswender, K. D., Ikizler, T. A., & Wang, T. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196869 · Cited by 15
Chronic renal artery insulin infusion increases mean arterial pressure in male Sprague-Dawley rats
Irsik, D. L., Chen, J., & Brands, M. W. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00374.2017 · Cited by 13
Euglycemic Insulin-Induced Hypotension in Autonomie Failure
Brown, R. T., Polinsky, R. J., & Baucom, C. E. (1989) · Clinical Neuropharmacology · doi:10.1097/00002826-198906000-00009 · Cited by 12
Cardiovascular regulation during insulin infusion into the carotid or vertebral artery in dogs
Hildebrandt, D. A., Smith, M. J., & Hall, J. E. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00010 · Cited by 12
Self-citationNostell, K. E. A., Lindåse, S. S., Edberg, H., & Bröjer, J. T. (2019) · Equine Veterinary Journal · doi:10.1111/evj.13110 · Cited by 12
Increased Feeding Speed Is Associated with Higher Subsequent Sympathetic Activity in Dogs
Ohtani, N., Okamoto, Y., Tateishi, K., Uchiyama, H., & Ohta, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142899 · Cited by 8
Failure of Acute Hyperinsulinemia to Alter Blood Pressure Is Not Due to Baroreceptor Feedback
Richey, J. S. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00272-6 · Cited by 7
Blood pressure in Warmblood horses before and during a euglycemic-hyperinsulinemic clamp
Nostell, K. E. A., Lindåse, S. S., & Bröjer, J. T. (2016) · Acta veterinaria Scandinavica · doi:10.1186/s13028-016-0247-y · Cited by 7
Blood pressure in Warmblood horses before and after a euglycemic-hyperinsulinemic clamp
Nostell, K. E. A., Lindåse, S. S., & Bröjer, J. T. (2015) · Acta veterinaria Scandinavica · doi:10.1186/1751-0147-57-s1-o5 · Cited by 4
Markakis, K., Alam, T., Jinadev, P., Chapman, A., Urwin, A., Thabit, H., Boulton, A., Rutter, M., & Leelarathna, L. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818822818 · Cited by 3
LACK OF SYMPATHETIC AUGMENTATION IN RESPONSE TO INTRAVENOUS LOAD OF GLUCOSE IN RABBITS
Takishita, S., Takata, Y., Abe, I., Tomita, Y., Kawazoe, N., Fujishima, M., & Fukiyama, K. (1991) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1991.tb01487.x · Cited by 1
Cited by
Zhang, Q., Xiao, S., Jiao, X., & Shen, Y. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02030-z · Cited by 477
Obesity, kidney dysfunction, and inflammation: interactions in hypertension
Hall, J. E., Mouton, A. J., da Silva, A. A., Omoto, A. C. M., Wang, Z., Li, X., & do Carmo, J. M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa336 · Cited by 265
Self-citationMetabolic syndrome-related kidney injury: a review and update
Lin, L., Tan, W., Pan, X., Tian, E., Wu, Z., & Yang, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.904001 · Cited by 139
High Remnant Cholesterol Level Potentiates the Development of Hypertension
Chen, M.-M., Huang, X., Xu, C., Song, X.-H., Liu, Y.-M., Yao, D., Lu, H., Wang, G., Zhang, G.-L., Chen, Z., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.830347 · Cited by 78
Adipose tissue is associated with kidney function parameters
Mueller-Peltzer, K., von Krüchten, R., Lorbeer, R., Rospleszcz, S., Schulz, H., Peters, A., Bamberg, F., Schlett, C. L., & Mujaj, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-36390-z · Cited by 25
Metadata
- Authors
- da Silva, A. A., do Carmo, J. M., Li, X., Wang, Z., Mouton, A. J., & Hall, J. E.
- Venue
- Canadian Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 36
- Issue
- 5
- Pages
- 671-682
- ISSN
- 0828-282X (ISSN-L)
- OpenAlex
- W3006318956
- Cited by
- 368
- References
- 139
- FWCI
- 24.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.